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Abstract
In the mammalian ovary, great interest in the expression and function of the bone morphogenetic
protein (BMP) family has been recently generated from evidence of their critical role in determining
folliculogenesis and female fertility. Despite extensive work, there is a need to understand the
cellular sites of expression of these important regulatory molecules, and how their gene expression
changes within the basic ovary cell types through the cycle. Here we have performed a detailed in
situ hybridization analysis of the spatial and temporal expression patterns of the BMP ligands (BMP-
2, -3, -3b, -4, -6, -7, -15), receptors (BMPR-IA, -IB, -II), and BMP antagonist, follistatin, in rat ovaries
over the normal estrous cycle. We have found that: i) all of the mRNAs are expressed in a cell-
specific manner in the major classes of ovary cell types (oocyte, granulosa, theca interstitial, theca
externa, corpora lutea, secondary interstitial, vascular and ovary surface epithelium); and ii) most
undergo dynamic changes during follicular and corpora luteal morphogenesis and histogenesis. The
general principle to emerge from these studies is that the developmental programs of
folliculogenesis (recruitment, selection, atresia), ovulation, and luteogenesis (luteinization,
luteolysis) are accompanied by rather dramatic spatial and temporal changes in the expression
patterns of these BMP genes. These results lead us to hypothesize previously unanticipated roles
for the BMP family in determining fundamental developmental events that ensure the proper timing
and developmental events required for the generation of the estrous cycle.
Background
The adult mammalian ovary is a complex tissue com-
posed of four fundamental cell types: the oocytes, granu-
losa, interstitial, and corpora luteal cells. Within this basic
quartet are many other cell types such as the ovary surface
epithelium and blood vessels in addition to the classic
subtypes of granulosa (membrana, periantral, cumulus,
and corona radiata), theca (interna and externa), and
luteal cells (granulosa and theca lutein). The coordinated
control of proliferation, differentiation, and apoptosis in
these cell types is the underlying basis for primate and
non-primate menstrual and estrous cycles, respectively.
The process by which each cell type obtains its state of dif-
ferentiation is the subject of intense study. The role of hor-
mones in this process is clear; however, new results
indicate that autocrine/paracrine or growth factor mecha-
nisms also have important roles.
The bone morphogenetic protein (BMP) family including
ligands, receptors, and binding proteins, has emerged as a
central player in ovary physiology and female fertility [1].
The BMPs represent a large subclass of the transforming
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growth factor-β (TGF-β) surperfamily of ligands whose bi-
ological responses are mediated by Ser/Thr kinase recep-
tors via the Smad-signaling molecules [2]. The mRNAs
encoding several BMP family members have been
identified in the murine ovary, including the ligands,
BMP-2 [3], BMP-3 [3], BMP-3b [3], BMP-4 [4], BMP-6 [5],
BMP-7 [4], BMP-15 [6–8], the BMP receptors, BMPR-IA,
BMPR-IB and BMPR-II [4] and the BMP binding protein,
follistatin (FS) [9]. In the murine, BMP-4 and -7 mRNA
have been identified in the theca interstitial cells [4], BMP-
6 and -15 in oocytes [5–8], BMPR-IA, BMPR-IB and
BMPR-II in oocytes and granulosa cells (GCs) [4], and FS
in granulosa and lutein cells [9,10].
The direct involvement of the BMP system in regulating
ovary function has been established. In vitro experiments
with rat GCs have demonstrated that BMP-4 and -7 inhib-
it and stimulate FSH-induced progesterone and estradiol
production, respectively [4]. In related studies BMP-6 and
BMP-15 were found to block FSH action through inhibit-
ing FSH-dependent adenylate cyclase activity and FSH re-
ceptor expression, respectively [11,12]. The importance of
these findings is underscored by the fact that FSH action is
obligatory for normal folliculogenesis and female fertility.
In addition, BMP-7 and -15, but not BMP-6 have stimula-
tory effects on GC DNA synthesis, indicating they may
play a mitogenic role in follicle growth [8,12,13]. The im-
portance of this finding is underscored by the fact that the
control of GC proliferation is crucial for follicle domi-
nance and atresia. Equally important, other studies have
shown that loss-of-function and naturally occurring mu-
tations in BMP ligands and receptors are associated with
dysregulation of folliculogenesis and ovulation [14–19].
Of particular interest is the finding that ewes having a mu-
tation in the bmp15  gene in both alleles are infertile
whereas the heterozygotes are superfertile [16]. Thus, the
bmp15 gene can control ovulation quota through a dos-
age-sensitive mechanism. Evidence that a mutation at the
Ser/Thr kinase domain of BMPR-IB leads to high fecundi-
ty in ewes [17–19] provides further support that BMP sig-
naling pathways play a key role in specifying ovary
function.
Although it is becoming clear that intrinsic BMPs are im-
portant players in the ovary, the cellular localization of
BMPs in the ovary is poorly understood, and a proper un-
derstanding of how the cell-specific expression of the BMP
system changes during the cycle is still lacking. As part of
our ongoing investigations of the roles of BMPs in ovary
physiology, we have analyzed the spatiotemporal expres-
sion patterns of the BMP system in the rat ovary cell types
during the normal estrous cycle.
Materials and Methods
Animals
Adult female Sprague-Dawley rats (2–3 months of age)
were housed (four animals per cage) in isolation under
controlled lighting conditions (14 h of light, 10 hr of
darkness; lights on from 0500 to 1900 h) at 23°C and
provided formulated rat chow and water ad libitum. Vagi-
nal smears were taken daily, and rats exhibiting two or
more consecutive 4-day estrous cycles were used. The ani-
mals (two at each time of the cycle) were sacrificed on
proestrus (P1000 and 2000 h), estrus (E0200 and E1000
h), diestrus I (DI, 1100 h) and diestrus II (DII, 1100 h).
The rats were handled in accordance with the NIH Guide
for the Care and Use of Laboratory Animals, and the pro-
tocols were approved by the University of California, San
Diego Animal Subjects Committee.
Plasmid construction for synthesizing riboprobes
Probes for in situ hybridization studies were made by RT-
PCR. Total RNA from adult rat ovaries was prepared and
single-stranded cDNA was synthesized by reverse tran-
scriptase and then subjected to PCR as described previous-
ly [20]. To design primers for PCR, DNA sequence
information was first collected from GenBank and prim-
ers for PCR were designed based on standard guidelines.
All sequence information was derived from rat cDNA
clones except for BMP-2, -7, BMPR-IB and BMPR-II whose
cDNA sequences in rat have not been deposited into the
GenBank. However, because cDNA sequences in human
and mouse are available from the GenBank, we designed
the PCR primers by choosing the homologous DNA se-
quence regions between human and mouse homologues.
Specifically, these primers are derived from the cDNA
clones at the following nucleotide numbers: #511 – #528
and #1066 – #1083 (accession number of the cDNA clone
is M22489) for BMP-2 [21]; #923 – #942 and #1341 –
#1360 (accession number D63860) for BMP-3 (Kangawa,
unpublished); #878 – #897 and #1292 – #1311 (acces-
sion number D49494) for BMP-3b [3]; #737 – #757 and
#1181 – #1200 (accession number Z22607) for BMP-4
[22]; #6 – #25 and #475 – #494 (accession number
U66298) for BMP-6 (Knittel et al., unpublished); #497 –
514 and #865 – #882 (accession number X56906) for
BMP-7 [23]; #441 – #460 and #876 – #895 (accession
number D38082) for BMPR-IA [24]; #528 – #547 and
#965 – #984 (accession number U89326) for BMPR-IB
(Astrom et al., unpublished); #525 – #544 and #895 –
#904 (accession number AF003942) for BMPR-II [25].
These primers were selected from different exons of the
corresponding genes to discriminate PCR products that
might arise from possible chromosome DNA contami-
nants. All PCR products were cloned into pBluescript SK+
and their DNA sequences confirmed. The plasmid con-
taining FS was constructed by sub-cloning of the XbaI-PstIReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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fragment derived for rat FS cDNA clone [9], pROF304 into
pBluescript SK+.
In situ hybridization
Ovaries were fixed in 4% paraformaldehyde at 4°C,
washed in PBS, dehydrated and embedded in paraffin.
Eight consecutive sections (8 µm) were cut from each
ovary and mounted onto poly-L-lysine-coated glass slides.
The sections were digested with proteinase K, acetylated,
washed and dehydrated as previously described [10,26].
Anti-sense and sense cRNA probes were prepared by
means of in vitro transcription using T3 or T7 RNA
polymerase. Hybridization was carried out with the 35S-
labeled RNA probe (4–6 × 106 cpm/ml) in a solution con-
taining 50% (vol/vol) deionized formamide, 0.3 M NaCl,
10 mM Tris (pH 8.2), 1 mM EDTA, 0.05% yeast tRNA, 10
mM dithiothreitol, 1 × Denhardt's solution and 10% dex-
tran sulfate. Hybridization solution (20 µl) was placed
over each section and covered with a 60 × 22 mm acid
washed, siliconized coverslip. Coverslips were sealed with
liquid DPX. Sections were hybridized for 16 h at 58–60 C
in a humidified chamber. After hybridization, the sections
were treated with ribonuclease A and washed in 15 mM
NaCl/1.5 mM sodium citrate at 60–62 C for 30 min. De-
hydrated slides were exposed to X-ray film for several
days. After adequate X-ray film images were obtained, the
ovary sections were treated with xylene, rinsed in 100%
ethanol, air dried, and then coated with Kodak NTB-2 liq-
uid autoradiograph emulsion. Slides were exposed for
four weeks at 4 C in a linedesiccated dark box. After expo-
sure, the slides were developed (Kodak D19, 3.5 min, 14
C), rinsed briefly in distilled water and fixed. After wash-
ing in distilled water for 1 h, slides were lightly counter-
stained with hematoxylin and eosin.
After an autoradiography and counterstaining, the sec-
tions were analyzed microscopically. The in situ experi-
ments were performed two times for each BMP ligand and
receptor. The intensity of the hybridization signals were
determined as previously reported [26–28]. A subjective
comparison of eight sections from each ovary from six an-
imals hybridized with the same concentrations of sense
and antisense cRNAs and exposed for the same time (4
weeks) was made. The hybridization signal was estimated
on a scale of 1+ to 4+ as originally described by Meunier
[29]: +, silver grains sparse, but positive hybridization; ++,
silver grains are numerous but do not cover the cell type
in question; +++, silver grains are very numerous and be-
gin to merge in some places; ++++, silver grains are very
dense and form a near uniform mass above the cell type
in question; +/-, there was heterogeneity in the hybridiza-
tion signal, e.g., some of the histological units contained
a signal, others did not; –, no detectable hybridization sig-
nal. The slides were analyzed simultaneously by two in-
vestigators and the results confirmed independently by
another researcher. In each experiment, tissues hybridized
with the sense probe were used as the negative control. In
all cases, the sense probes showed no specific hybridiza-
tion to the adult ovaries above background (see for exam-
ple Fig. 1C).
Results
Expression of BMP-2 mRNA
In adult rat ovaries, BMP-2 mRNA is highly expressed in
the GC of atretic follicles and at relatively high levels in
the GC of Graafian follicles (GF) and some corpora lutea
(CL) (Table 1, Fig. 1A,1B). BMP-2 mRNA is also expressed
at lower levels in the secondary interstitial cells (SIC) and
theca interstitial cells (TIC) but undetectable in other ova-
ry cell types (Table 1). In the SIC, BMP-2 mRNA was con-
stitutively expressed at low to moderate levels over the
cycle. A weak variable expression was sometimes seen in
the TIC (Table 1).
In the GC, BMP-2 mRNA is expressed in a precise manner,
indicating that gene activity is regulated during follicle de-
velopment. A weak hybridization signal was first detected
in some GC of early primary follicles, consistent with
BMP-2 gene activation during recruitment. As folliculo-
genesis progressed, BMP-2 mRNA expression increased
rapidly reaching maximal levels in the GC of secondary
follicles. The expression of GC BMP-2 mRNA was hetero-
geneous. In preantral follicles, BMP-2 mRNA expression
was confined mainly to the membrana GC with little or
no expression in the corona radiata GC next to the oocyte
(Fig. 1D,1E). This indicates that the GC become function-
ally diverse very early in follicle development, i.e. about
the time the follicle has two layers of GC. As the follicle
undergoes its development to the preovulatory stage (i.e.
from selection at E 0200 h through ovulation at E 0200 h
the next cycle), the membrana, but not the cumulus and
periantral GC, express high levels of BMP-2 mRNA (Fig.
1F,1G). These findings indicate that the oocyte may regu-
late GC BMP-2 gene expression by a morphogen gradient
mechanism. Finally the highest levels of BMP-2 mRNA in
the ovary were seen in the GC of atretic follicles (Fig.
1H,1I).
BMP-2 mRNA expression in the dominant follicle was
rapidly down-regulated following ovulation. As such,
there was no detectable BMP-2 mRNA in the new CL-I
during luteinization i.e. E 2000 h to DI 1100 h (Fig.
1J,1K). The message was re-expressed at DII 1100 h (lute-
olysis) with strong hybridization for BMP-2 appearing in
clusters of endothelial cells scattered throughout the CL-I
(Fig. 1A,1B,1L,1M). This correlation suggests a possible
function for endothelial-derived BMP-2 in luteolysis (Fig.
1N).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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Figure 1
In situ hybridization of BMP-2 mRNA in the ovaries of adult cycling rats. Brightfield (A, D, F, H, J, L, N) and Darkfield (B, C, E, 
G, I, K, M). A, B: Sections from a DII 1100 h ovary (4X); new corpus luteum (CL-I); atretic follicle (AF); secondary interstitial 
cells (SIC); healthy Graafian follicle (GF); C: Negative control hybridized with sense BMP-2 cRNA probe; D, E: Secondary fol-
licle with 3–5 layers of GCs at DII 1100 h (20X). Note positive membrana GC at periphery. F, G: Dominant follicle at DII 1100 
h (10X); Positive membrana GC (MGC); Negative oocyte (O), cumulus GC (CC), periantral GC (PA) and theca (T); H, I: 
Atretic follicle at P 1000 h showing strongly positive GC (10X); J, K: Negative newly formed CL-I at E 0200 h (4X); Positive GF 
and preantral follicle (arrow); L, M: New CL-I after initiation of luteolysis at DII 1100 h showing clusters of positive cells (20X); 
N: Higher magnification (40X) of CL-I in L showing positive endothelial and granulosa lutein cells (GLC).
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Expression of BMP-3 and -3b mRNA
The hybridization signal for BMP-3 was relatively weak in
the ovaries examined (data not shown). BMP-3 mRNA ex-
pression was present in the TIC of healthy Graafian folli-
cles and in the theca lutein cells (TLC) of the CL-I at DI
1100 h (Table 1). This is consistent with a role for theca-
derived BMP-3 in regulating the dominant follicle and CL.
A strong expression of BMP-3b mRNA was seen in some
ovaries (Table 1). During folliculogenesis, the theca cells
(T) of the theca interna (TI) and externa (TE) of dominant
Table 1: Cellular localization and relative intensity of mRNAs for BMPs in ovaries of adult cycling rats.
TISSUE BMP-2 BMP-3 BMP-3b BMP-4 BMP-6 BMP-7 BMP-15 BMPR-IA BMPR-IB BMPR-II FS
Oocyte
P r i m o r d i a l ------- ++ + / + + / - -
Primary - - - - - - + ++ +++/++ + -
Secondary - - - - +++/+ - ++++/++ +++ ++++ +/- -
Tertiary - - - - +++ - ++++ +++ +++ +/- -
Dominant - - - - +++ - ++++/
+++
++ +++ +/- -
Atretic - - - - +++/++ - ++/+ +++/++ ++ +/- -
Granulosa Cells
P r i m o r d i a l ------- + / - + / - - -
P r i m a r y + / - ------ + + / - +-
Secondary ++/- - - - +++/- - - ++/+ ++++ +++/++ ++
Tertiary +++/- - - - +++/- - - ++ ++++ +++ ++++
Dominant +++/- - - - +/- - - ++ ++++ +++ ++++
Atretic ++++ - - - +++ - - ++ ++++ +++ +/-
Theca-interstitial cells
P r i m o r d i a l ------- - - - -
Primary - - - + - - - - - - -
Secondary +/- - - ++/- - ++/- - + + - -
Tertiary +/- +/- + +++/- - +++/- - ++/+ + - -
Dominant +/- +/- ++++/- ++++/- - +++/- - ++/+ ++ - +/-
A t r e t i c + / --+ / - + / --+ / -- + + - -
Theca externa - - ++++/- ++++/- - - + ++/- -
Corpora lutea – Healthy
Granulosa Lutein +/- - - +/- ++/+ - - ++/+ + ++ ++++
Theca Lutein +/- +/- +/- +/- - ++/- - ++/+ + +/- +++
Vascular Endothelial - - - - - - - +/- +/- -
Theca Externa - - ++/+ +++ - - - +/- ++/+ -
Corpora lutea – Luteo-
lytic
+++/- +/- - ++ +/- - - + +++/- +/- -/++++
Vascular System
Endothelium - - - +++ +++/- - - +/- - +/- -
S m o o t h  M u s c l e ------- + / - - --
Tunica Adventitia - - - - - - +/- ++ - -
Secondary-interstitial 
cells
++/+ - - - - +/- - + ++/+ - -/++++
Surface epithelium - - +++/- +++/- +++ - - +/- - - -
Sex Cords - - ++++ +++ - +++ - + +++ +/- -
The intensities of the hybridization signals indicated above represent a subjective consensus of all sections examined from all the ovaries collected 
from all of the animals over the estrous cycle (see Materials and Methods). The hybridization signals were estimated on a scale of - to 4+ as 
described in Materials and Methods. The slashes represent the variability in signal intensity that was observed for any given histological unit. The 
nature of this variability, whether it be temporal (cycle-dependent or developmental), or spatial (heterogeneity within or between the histological 
unit), is fully described in the Results section.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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follicles strongly expressed BMP-3b mRNA (Fig.
2A,2B,2C). In the TI, the expression appeared mainly in
the TIC located nearest the TE (Fig. 2C). After ovulation
the signal was reduced. In the CL-I, BMP-3b mRNA was
expressed at low to moderate levels in the TLC and TE cells
during luteinization (Fig. 2D,2E). Little or no BMP-3b
mRNA was evident in degenerating CL (Table 1, Fig.
2A,2B). Interestingly, there was high expression in the
ovary surface epithelium (OSE) (Fig. 2F), and in the epi-
thelial cells of the sex cords (SC) located in the hilum of
the ovary (Fig. 2G). In atretic follicles BMP-3b mRNA ex-
pression was undetectable (Fig. 2H,2I).
Expression of BMP-4 mRNA
BMP-4 mRNA was expressed in a variety of ovary cell types
with the highest levels appearing in the theca, CL, OSE, SC
and endothelium of some blood vessels (Table 1, Fig.
3A,3B,3C). BMP-4 mRNA was constitutively expressed at
high levels in both the SC (Fig. 3C) and the endothelium
lining the large sinusoids in the mesovarium (Fig. 3D). A
weak hybridization signal was occasionally seen in some
oocytes of primary follicles, but it was rare.
In the theca, the levels of BMP-4 mRNA change during fol-
liculogenesis. A weak BMP-4 signal was first detectable in
primary follicles, being localized to a few stroma fibrob-
lasts near the basal lamina. This finding is consistent with
the intriguing idea that the theca may begin to develop
very early in preantral folliculogenesis, i.e. during the ini-
tial steps of primary follicle development. In secondary
follicles, BMP-4 mRNA was present at moderate levels in
an outer layer of flattened cells (the TE) and in a subset of
TIC adjacent to these cells (Fig. 3E,3F,3G). BMP-4 mRNA
was expressed at high levels in the theca of developing
dominant follicles, again being localized to the TE and ad-
jacent TIC (Fig. 3H,3I,3J). Unlike healthy follicles, BMP-4
mRNA was very low or undetectable in atretic follicles.
High levels of BMP-4 mRNA continue to be expressed in
the TE of the CL throughout luteogenes, i.e. luteinization
(E 0200 h to DI 1100 h), and luteolysis (DII 1100 h to E
0200 h the next cycle) (Fig. 3K,3L). A potentially impor-
tant finding is that the OSE covering the ovulated follicle
and newly formed CL-I expressed high levels of BMP-4
mRNA while little or no BMP-4 mRNA was detected in
other areas of the surface epithelium (Fig. 3M,3N,3O).
This is consistent with a role for BMP-4 in OSE regenera-
tion following ovulation.
Expression of BMP-6 mRNA
BMP-6 mRNA was present in the oocytes, GC, CL, blood
vessels and the OSE (Table 1, Fig. 4A,4B). In the vascular
system, BMP-6 mRNA was continuously expressed at rela-
tively high levels in the endothelial cells of some large ar-
teries and veins in the medulla (Fig. 4C). Thus BMP-6, like
BMP-4, could have a role in ovarian blood circulation.
BMP-6 mRNA showed relatively high expression in the
OSE throughout the cycle, suggesting a general, non-regu-
lated role for BMP-6 in the OSE and/or adjacent tissues
(Fig. 4A,4B).
The expression of BMP-6 mRNA in oocytes was develop-
mentally regulated. There was no detectable BMP-6
mRNA in primordial and primary follicles (Table 1); how-
ever a weak hybridization signal was detected in oocytes
of early secondary follicles when the second layer of GCs
was forming (Fig. 4D). Thereafter, expression increased
sharply and was maximal in oocytes after the fourth layer
of GC had developed (Fig. 4E,4F). High levels of BMP-6
mRNA were present in oocytes of all Graafian follicles,
both healthy and atretic (Fig. 4A,4B,4E,4F,4G,4H,4I,4J).
The developmental changes in oocyte BMP-6 mRNA ex-
pression showed no obvious cyclic variation.
Like oocytes, BMP-6 mRNA was first detected in the GC at
the early secondary stage. Expression increased as the
follicle grew and was maximal after the fourth layer of GC
had formed (Fig. 4D,4E,4F). In the preantral follicles,
only the membrana GC expressed BMP-6 mRNA, consist-
ent with a role of the oocyte in regulating GC BMP-6 ex-
pression (Fig. 4E,4F). BMP-6 mRNA was not detectable in
the GC of dominant follicles (Fig. 4G,4H). This loss of
BMP-6 mRNA became evident soon after selection at E
0200 h, and continued through dominant follicle devel-
opment. This suggests the inhibition of GC BMP-6 gene
activity may be required for the formation of dominant
follicles. The finding that BMP-6 mRNA is strongly ex-
pressed in GC during atresia (Fig. 4I,4J) is consistent with
this idea. It is notable that BMP-6 mRNA was expressed in
the TE of the CL-I from ovulation throughout luteolysis
(Fig. 4A,4B,4K,4L).
Expression of BMP-7 mRNA
As with BMP-4, relatively high expression of BMP-7
mRNA was identified in the theca, CL and SC (Table 1 and
Fig. 5A,5B,5C). A specific pattern of BMP-7 expression was
identified in the theca during folliculogenesis and luteo-
genesis. The theca of developing follicles first exhibited
BMP-7 mRNA when the second layer of GC appeared, i.e.
at the primary/secondary follicle transition (Table 1).
Subsequent follicle growth was accompanied by increased
BMP-7 mRNA expression which reached high levels in the
theca of dominant follicles (Fig. 5D,5E). An intriguing
feature of theca BMP-7 mRNA expression is that it restrict-
ed to the inner most layer, being present in a subset of fi-
broblast-like cells juxtaposed to the basal lamina and a
sub-population of adjacent TIC (Fig. 5D,5E,5F). Notably,
this pattern of theca BMP-7 mRNA expression is just the
opposite of BMP-4 mRNA whose expression is limited to
the outer half of the theca. These observations are consist-
ent with the novel concept that the TIC of the TI representReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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Figure 2
In situ hybridization of BMP-3b mRNA in ovaries of adult cycling rats. All photographs are from ovaries at DI 1100 h. Brightfield 
(A, C, D, F, G, H) and Darkfield (B, E, I). A, B: Low power photomicrograph showing positive theca (T), ovary surface epithe-
lium (OSE), sex cords (SC), and CL-I (4X); C: Higher power (40X) of theca in B showing strongly positive theca interna (TI) 
and theca externa (TE); D, E: New CL-I showing positive signal in some theca lutein (TLC) and TE cells (20X); F: Positive OSE 
(40X); G: Positive SC (40X); H, I: Positive TI in healthy GF. Note negative TI of atretic AF follicle (10X).
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Figure 3
In situ hybridization of BMP-4 mRNA in ovaries of adult cycling rats. Brighfield (A, C, D, E, G, H, J, K, M, O) and Darkfield (B, F, 
I, L, N). A, B: Sections from P 1000 h ovaries (4X). Positive OSE, and T; weakly positive CL; negative preantral follicles (arrow 
heads); C: Positive SC () at P 1000 h (40X); D: Positive endothelial cells of large sinusoid (40X); E, F: Secondary follicle at P 
1000 h (20X) showing positive cells (arrow heads) at periphery of T. G: High power (40X) of E showing positive theca intersti-
tial cells (TIC) (arrows) in outer half of TI and positive cells (arrows) in the TE. H, I: Dominant follicle at P 2000 h showing 
positive theca (10X); J: Higher magnification (40X) of H showing positive TE and adjacent TIC in the dominant follicle. K, L: 
Older CL-I (10X) at E 1000 h of the next cycle showing positive TE (arrow heads); M, N: CL-I at P 1000 h (20X); showing pos-
itive TE (arrow head) and OSE only over the new CL; O: Higher magnification of CL-I showing positive OSE and underlying TE 
(40X).
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Figure 4
In situ hybridization of BMP-6 mRNA in ovaries of adult cycling rats. Brightfield (A, C, D, E, G, I, K) and Darkfield (B, F, H, J, L). 
A, B: Sections from DI 1100 h ovary (4X); positive GC in GF; preantral follicles with positive oocytes and GC (arrow heads); 
positive CL-I and positive OSE. C: Artery in mesovarium at P 1000 h (40X); positive endothelium. D: Early secondary follicle at 
E 0200 h (40X) with weakly positive oocyte; germinal vesicle (GV). E, F: Early secondary follicle at E 1000 h (20X); positive 
oocyte; positive peripheral membrana GC (arrow heads); negative corona radiata; G, H: Ovulating follicle at E 1000 h (4X) 
showing positive oocyte and negative MGC, CC, and PA cells. I, J: Atretic follicle (AF) at E 1000 h (10X) with positive oocyte 
(O) and GC. K, L: New CL-I at DI 1100 h (20X) showing positive TE and OSE.
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two classes based on the BMP mRNAs that they expressed.
As atresia occurs, BMP-7 mRNA is rapidly decreased to
low or undetectable levels, indicating that BMP-7 is a
marker for healthy follicles.
Following ovulation, BMP-7 mRNA was expressed in
moderate amounts in groups of TLC of the newly formed
CL-I from E 1000 h to DI 1100 h (Fig. 5A,5B,5G), however
after the initiation of luteolysis at DII 1100 h, BMP-7
mRNA becomes undetectable. Thus, BMP-7 transcripts are
down-regulated in both the luteolytic CL and apoptotic
follicles.
Expression of BMP-15 mRNA
BMP-15 mRNA expression was strictly germ cell specific
and was developmentally regulated during normal follic-
ulogenesis over the estrous cycle (Table 1, Fig. 6A,6B).
BMP-15 mRNA was absent in oocytes of primordial folli-
cles. When the squamous GC start to become cuboidal a
weak hybridization signal was detected in the oocyte (Fig.
6C), indicating BMP-15 gene activation is closely correlat-
ed with recruitment. Low levels of expression were seen
throughout the growth of the primary follicle, but began
to increase when a second layer of GC was forming (Fig.
6D). As follicle development proceeded, the expression of
BMP-15 mRNA increased dramatically and very high near
maximal levels were seen after the third layer of GC had
formed (Fig. 6E). Expression was maintained at high
levels from this stage through ovulation (Fig. 6F). It is no-
table that the BMP-15 mRNA levels appeared to decrease
during atresia (Table 1, Fig. 6G). The stage in the cycle did
not appear to affect the BMP-15 expression.
Expression of BMPR-IA mRNA
The BMPR-IA mRNA was ubiquitously expressed in the
adult rat ovary, indicating a broad function in a variety of
ovary cell types during the cycle (Table 1, Fig. 7A,7B). The
highest expression was in the oocytes, GC, theca, and CL,
with the greatest concentrations appearing in developing
oocytes (Table 1). Constitutively low to moderate expres-
sion was seen in the vascular system, SIC, SE, SC, and TE
(Table 1).
The potential importance of oocyte BMPR-IA mRNA is il-
lustrated by its continuous expression throughout the
course of oogenesis as it occurs within the adult ovary. A
weak hybridization signal could be identified in primor-
dial follicles (Fig. 7C). In the early stages of primary folli-
cle development the levels of BMPR-IA mRNA in the
oocyte increased and were maximal in late preantral folli-
cles (Fig. 7D, 7F). During the development of the domi-
nant follicle, BMPR-IA mRNA was abundantly expressed
but the signal appeared weaker than in the secondary
follicles (Fig. 7G,7H). In atretic follicles, BMPR-IA mRNA
was highly expressed (Fig. 7I,7J).
In the GC (Fig. 7C,7D,7G,7H) the pattern of BMPR-IA
mRNA expression during folliculogenesis was similar to
that found in developing oocytes. In CL, moderate
amounts of BMPR-IA mRNA were expressed as it under-
went luteinization and luteolysis. In the theca, BMPR-IA
mRNA expression was not notable, except for a stage-spe-
cific increase among the early tertiary follicles at P 1000 h
(Fig. 7E,7F).
Expression of BMPR-IB mRNA
The expression of BMPR-IB mRNA was strong in oocytes,
GC, CL, and SC (Table 1, Fig. 8A,8B,8C). There was also
expression in the theca, vascular, and SIC tissues, but at
lower levels. In blood vessels, the BMPR-IB mRNA was
moderately expressed in the tunica adventitia of the ovar-
ian arteries, suggesting a role for the BMPs in the ovary ar-
terial system (Fig. 8D). In the theca, some TIC and TE cells
showed BMPR-IB expression with the highest levels ap-
pearing in dominant follicles at proestrus (Table 1, Fig.
8A,8B,8H,8I).
As with BMPR-IA, the message for BMPR-IB was clearly
visible in oocytes of primordial and primary follicles (Fig.
8E). At the primary/secondary follicle transition, a sharp
increase in oocyte BMPR-IB mRNA expression occurred
(Fig. 8G). High expression was observed in all dominant
follicles. In the GC there were also clear follicle stage-spe-
cific shifts in BMPR-IB mRNA expression. BMPR-IB
mRNA was first detected in some cuboidal GC of newly
recruited primary follicles (Fig. 8E,8F). The formation of a
second layer of GC at the primary/secondary follicle tran-
sition was marked by a sharp increase in BMPR-IB mRNA
expression in all the GC (Fig. 8G). The entire mass of GC
in developing dominant follicles strongly expressed
BMPR-IB mRNA (Fig. 8A,8B,8H,8I). Cells in atretic folli-
cles (GC and oocyte) continued to show high expression
of BMPR-IB mRNA (Fig. 8J,8K).
There was a marked decrease in BMPR-IB mRNA follow-
ing ovulation, whereby little or no expression was evident
in the CL-I during the luteinization i.e. E 0200 h to DI
1100 h (Table 1). However, when luteolysis was initiated
at DII 1100 h, the BMPR-IB mRNA is expressed in the TE
(Fig. 8L,8M). Then at P 2000 h, there was strong BMPR-IB
expression in both the TE and in groups of endothelial
cells scattered throughout the luteolytic CL-I (Fig.
8N,8O).
Expression of BMPR-II mRNA
Over the cycle, the GC expressed the highest levels of
BMPR-II mRNA, with the CL, SC, and the vascular en-
dothelium showing low variable levels of expression
(Table 1, Fig. 9A,9B). Although the oocytes of most folli-
cles showed no hybridization signal above background, a
weak expression was consistently seen in some oocytes ofReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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Figure 5
In situ hybridization of BMP-7 mRNA in ovaries of adult cycling rats. Brightfield (A, C, D, F, G) and Darkfield (B, E). A, B: Sec-
tions of DI 1100 h ovaries (4X); positive Graafian follicle (GF); positive new CL-I; negative old CL-I and SIC; C: Positive sex 
cords at E 0200 h (40X); D, E: Dominant follicle at P 2000 h (4X) showing positive theca interna. F: Higher magnification 
(40X) of D showing positive fibroblast-like cells beneath the basal lamina and adjacent positive TIC (). G: CL-I at DI 1100 h 
showing positive theca lutein cells (40X).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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Figure 6
In situ hybridization of BMP-15 mRNA in ovaries of adult cycling rats. Brightfield (A, C, D, E, F, G) and Darkfield (B). A, B: Sec-
tions from a DII 1100 h ovary (4X); Positive oocytes in preantral follicles (arrow heads); C: Early primary follicle at DI 1100 h 
showing one cuboidal GC and a weakly positive oocyte: note most of the signal is located within the GV or nucleus (40X). D: 
Preantral follicle at P 1000 h (40X) in the process of forming a second layer of GC. Note a weakly positive oocyte; E: Mid sec-
ondary follicle at DII 1100 h showing a strongly positive full-grown oocyte surrounded by three to four layers of GC (20X); F: 
Mid cross section of a strongly positive oocyte of a dominant follicle at P 1000 h (40X). Hybridization signals are seen predom-
inantly in the ooplasm, with some signal associated with the outer region of the nucleolus (arrow head); G: An atretic follicle at 
E 0200 h (40X) with a moderately positive oocyte that has resumed meiosis
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Figure 7
In situ hybridization of BMPR-IA mRNA in ovaries of adult cycling rats. Brighfield (A, C, D, E, G, I) and Darkfield (B, F, H, J). A, 
B: Sections from DII 1100 h ovaries (4X). Positive oocyte; C: Positive oocytes (O) and GC in primordial and primary follicles 
at P 1000 h (40X); D: Positive secondary follicle with three layers of GC at DII 1100 h (20X); E, F: Positive oocyte of an early 
tertiary follicle at P 1000 h. Note expression in TI (arrowheads) (10X); G, H: Preovulatory follicle at E 1000 h showing positive 
oocyte (O); Note weak signal in GC and TI (4X); I, J: Atretic follicle at E 1000 h showing positive O and GC (10X).
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Figure 8
In situ hybridization of BMPR-IB mRNA in ovaries of adult cycling rats. Brightfield (A, C, D, E, F, G, H, J, L, O) and Darkfield (B, 
I, K, M, N). A, B: Sections from a P 2000 h ovary (4X); positive GC in dominant (DF), AF and preantral follicle (arrow head); 
Note positive oocyte. C: Positive sex cords at P 1000 h (40X);D: Artery at P 2000 h (40X) showing positive tunica adventita 
(TA) next to smooth muscle (SM); E: Positive oocytes (O) in primordial and early primary follicles at DI 1100 h (40X); F: Pos-
itive O in late primary follicle with single layer of weakly positive GC at P 2000 h (40X); G: Strongly positive O and GC in sec-
ondary follicle at E 1000 h (20X); H, I: Higher magnification (20X) of wall of DF at P 1000 h showing positive GC, TE, and a 
number of TIC in the outer zone of TI; J, K: Positive AF at P 1000 h (10X); L, M: CL-I at DII 1100 h showing positive TE 
(arrow heads); N: CL-I at P 2000 h showing positive TE at periphery (arrow head) and clusters of positive cells scattered 
within the CL (); O: Higher magnification (40X) of N showing positive endothelial (EC) and a few adjacent weakly positive 
granulosa lutein cells (arrow head).
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primary and early secondary follicles (Table 1, Fig. 9C).
There was no detectable BMPR-II mRNA expression in GC
of the primordial follicles; however, a low expression was
detected in primary follicles after recruitment (Fig. 9C).
During preantral follicle growth, expression increased
reaching high maximal levels in the GC of secondary fol-
licles (Fig. 9A,9B). High expression was seen in all the GC
of the dominant follicle, except at ovulation when there
appeared to be a decrease in BMPR-II mRNA within the
cumulus GC (Fig. 9D,9E). Ovulation was accompanied by
a rapid decrease in the levels of BMPR-II mRNA. During
the life of the CL, low to moderate expression was seen in
the lutein, but not the endothelial cells (Fig. 9H). BMPR-
II mRNA was strongly expressed in all GC during atresia
(Fig. 9F,9G).
Expression of FS mRNA
The message for the BMP antagonist, FS, was highly ex-
pressed during the estrous cycle, being present in the GC,
CL, and SIC (Table 1, Fig. 10A,10B). It is notable that a
striking change in FS mRNA expression occurred in the
SIC during the preovulatory period. In all the SIC, FS
mRNA was absent during most of the cycle, but at P 2000
h, it was very strongly expressed (Fig. 10C,10D,10E). This
observation suggests a burst of FS gene activity that may
be associated with the preovulatory surge of LH during
proestrus.
Folliculogenesis and luteogenesis were accompanied by
striking changes in FS expression some of which were cy-
cle dependent. During the preantral stages of folliculogen-
esis, FS mRNA was poorly expressed in the GC. By
comparison FS mRNA was highly expressed in all the GC
of the dominant follicles over the cycle (Table 1, Fig.
10A,10B). Then, during atresia, FS mRNA was low or ab-
sent in the GC (Table 1). Thus, FS gene activity and follicle
dominance appear to be physiologically coupled. After
ovulation, the CL showed high levels of FS mRNA expres-
sion during luteinization at E 0200 h and E 1000 h and
moderate levels at DI 1100 h (Fig.
10F,10G,10H,10I,10J,10K). The high expression of FS
mRNA correlates with a high expression of progesterone
by the new CL-I. Interestingly, FS mRNA fell to non-de-
tectable levels in the CL-I when luteolysis occurred at DII
1100 h (Fig. 10L,10M). FS mRNA remained undetectable
in the CL until P 2000 h when high expression was in-
duced in a subset of lutein cells (Fig. 10N,10O). This high
expression in the luteolytic CL-I persisted through estrous
of the next cycle.
Discussion
To better understand the physiological role of the BMP
family in ovarian function, the spatiotemporal expression
patterns of a number of relevant BMP ligands, receptors,
and a binding protein were determined by in situ hybrid-
ization in rat ovaries over the estrous cycle. The general
principle to emerge from our data is that the developmen-
tal programs of folliculogenesis (recruitment, selection,
and atresia), ovulation and luteogenesis (luteinization
and luteolysis) are accompanied by precise cell-specific
changes in the expression of the genes encoding the BMP
family. Therefore, we hypothesize the regulated
expression of BMP gene activity forms a part of the con-
trolling network that ensures the proper timing of the de-
velopmental events that generates a normal estrous cycle.
The finding that the genes encoding the three types of
BMP receptors are expressed in primordial follicles indi-
cates that these fundamental reproductive units are targets
for the BMPs. In this regard, we have shown recently that
BMP-7 can promote primordial follicle growth [13]. Thus,
it is reasonable to propose that one function of the BMP
receptors in the primordial follicle might be to mediate
the activation of recruitment by endogenous BMP-7. As
there is no evidence that primordial follicles express BMP
ligands, the mechanism by which this activation occurs
would be paracrine, most likely involving BMP-7 from
adjacent tissues such as the theca, secondary interstitial, or
sex cords.
Unlike lower vertebrates, the developing mammalian fol-
licle is composed of more than one layer of GC. One of
the most important concepts generated in the ovary BMP
field is that oocyte derived GDF-9 [14] plays a role in the
mechanisms governing the development of the second
layer of GC i.e. the primary /secondary follicle transition.
The question of how GDF-9 controls this step has yet to
be answered. Our data show that the primary/secondary
transition stage is accompanied by some rather dramatic
changes in BMP expression including increased expres-
sion of: i) BMP-6, BMP-15, and BMPR IB in the oocyte; ii)
BMP-2, BMP-6, and BMPR-IA, -IB and -II in the GC; and
iii) BMP-4 and BMP-7 in the theca. Because folliculogen-
esis in the murine proceeds to the preovulatory stage in
the absence of BMP-6 [30], BMP-15 [15], and BMPR-IB
[31], one can assume that the marked increases in these
regulatory molecules are not essential for the develop-
ment of a second layer of GC. The question of whether the
increased expression of BMPR -II and BMP-2, -4, and -7
contribute to this important developmental event re-
mains to be answered. One interesting implication of our
BMP-2 data is that the GC have already attained different
states of differentiation by the early stages of secondary
follicle development Based on previous work [32,33], it is
not unreasonable to propose that oocyte morphogens
may have control over GC fate beginning as early as the
primary/secondary follicle transition. It will be interesting
to investigate how this phenomenon fits into the mecha-
nisms underlying the primary/secondary follicle
transition.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
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Figure 9
In situ hybridization of BMPR-II mRNA in ovaries of adult cycling rats. Brightfield (A, C, D, F, H) and Darkfield (B, E, G). A, B: 
Sections from DI 1100 h ovaries (4X). Positive new CL-I; positive GC in GF, AF, and preantral follicles (arrow heads); negative 
secondary interstitial cells (SIC); C: Early secondary follicle showing positive GC surrounding weakly positive oocyte (40X); D, 
E: Dominant preovulatory follicle at E 0200 h (4X); positive MGC and negative oocyte (O) surrounded by weakly positive CC. 
F, G: Atretic follicle at P 2000 h (10X) showing positive GC. H: Higher magnification of new CL-I in panel A (40X); moderately 
positive lutein cells; negative endothelial cells (EC) and theca externa (TE).
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Figure 10
In situ hybridization of FS mRNA in ovaries of adult cycling rats. Brightfield (A, C, E, F, H, J, L, N) and Darkfield (B, D, G, I, K, M, 
O). A, B: Sections from a DI 1100 h ovary (4X) showing strongly positive GC in GF and weakly positive GC in preantral folli-
cles (arrow heads); C, D: Positive SIC at P 2000 h (4X); E: Higher magnification of panel C showing high density of silver grains 
(black dots) over the SIC (40X); F to O: FS expression in CL-I during luteogenesis (4X) i.e. luteinization (E 0200 h, E 1000 h, 
DI 1100 h) and luteolysis (DII 1100 h, P 2000 h).
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Our results demonstrate for the first time that the theca in-
terna of healthy follicles is composed of two distinct pop-
ulations of theca interstitial cells (TIC). One group, which
expresses BMP-4, is present as an outer layer of cells juxta-
posed to the theca externa (TE), and another, which
expresses BMP-7, is present at the proximal side of the the-
ca interna near the basal lamina of the follicle. These dif-
ferences can be found throughout folliculogenesis,
beginning during the secondary stage. This, together with
the failure to detect BMP-4 and 7 in the theca of atretic fol-
licles, supports the idea that the cellular sites and coordi-
nate expression of these BMP genes may have important
regulatory roles in maintaining folliculogenesis. In this re-
gard, a recent study has demonstrated the ability of BMP-
4 to inhibit cyclic AMP-stimulated androgen production
by the cultured human theca cell line, presumably by ac-
tivating BMP receptors (BMPR-IA, -IB, and -II) which are
expressed in these cells [34]. Because theca derived andro-
gen is required for follicle estrogen biosynthesis and has
been implicated in ovary pathology [35], it will be inter-
esting to determine how the expression and functions of
these TIC-specific BMPs are integrated into the overall
processes of physiology and pathophysiology. Besides the
TI, a high level of BMP expression (BMP-3b and 4) is
found within the smooth muscle cells of the TE during the
process of follicle formation. Very little is known about
the role of the TE in folliculogenesis: however this new
finding raises the possibility that BMP-3b and -4 could
have autocrine actions on TE histogenesis and/or para-
crine actions on theca/follicle morphogenesis.
The rapid cessation of mitosis and the expression of apop-
tosis in the GC is the sinequanone of follicle atresia. Our
results suggest a possible role for BMPs in follicle atresia.
The supporting data are as follow. First, a striking feature
of atresia in the rat ovary is the cessation of BMP
expression (BMP-3b, -4, and -7) within the theca compart-
ment. This observation is particularly interesting with re-
spect to BMP-7. In previous work, we demonstrated that
BMP-7 could stimulate DNA synthesis in rat GC [13], as it
does in human osteoblasts [36]. Equally relevant, several
reports have demonstrated the role for BMP-7 in prevent-
ing apoptosis in other cell systems [37,38]. Together,
these data suggest that theca-derived BMP-7 might be a
follicle survival factor through its ability to enhance GC
proliferation and suppress apoptosis. Second, atresia is ac-
companied by a relatively high level of expression of BMP-
2 and -6 and the BMPR-IA, -IB, and -II. Significantly, this
occurred in the absence of the BMP antagonist, FS. Thus,
it is possible that GC BMP receptor signaling pathways are
under maximal stimulation by BMP-2 and -6 during
atresia. How this phenomenon contributes to atresia is
unknown, but our finding [12] that BMP-6 inhibits FSH
signaling is relevant because there is compelling evidence
that continuous FSH stimulation is essential for follicle
survival.
The expression of the family of BMPs (ligands, receptors
and a binding protein) in the fundamental cell types of
the dominant follicles (DF) argues for a physiological role
of an intrinsic BMP in directing growth and cell fates in
the DF. This is supported by two main lines of evidence.
First, we found that the genes encoding the BMP receptors
(BMPR-IA, -IB, -II) are highly expressed in the DF through-
out its course of development. And second, the BMP lig-
ands (BMP-4, -6, -7, and -15) act on the GC to control the
level of mitosis and FSH receptor signaling [1]. In this re-
gard, one particularly interesting observation is the
dramatic loss of BMP-6 mRNA in the GC when the DF is
selected at E 0200 h. Because BMP-6 can prevent FSH ac-
tion [12], the rapid loss of BMP-6 expression may be re-
quired for FSH to exert its crucial functions during DF-
development. The secondary rise of FSH on estrous morn-
ing is obligatory for DF selection, and we have prelimi-
nary data showing that FSH induces the loss of BMP-6
mRNA in GC. Thus, the secondary rise of FSH may down
regulate BMP-6 expression in the DF. It is notable that the
absence of GC BMP-6 is a marker for the DF. Finally, with
regard to FSH action, FS has been shown to neutralize the
bioactivity of the FSH inhibitor, BMP-15 [39]. It is possi-
ble, therefore, that the strong expression of FS by the DF
may serve to modulate BMP-15 action such that sufficient
FSH receptors are expressed in the GC to permit the devel-
opment of a preovulatory follicle.
A role for the BMPs in regulating luteogenesis is strongly
suggested our data. Some key findings are as follows. First,
the classical view of CL development is that luteinization
is inhibited by oocyte-derived luteinization inhibitors
[32,40,41], two of which have been identified as BMP-6
and -15 [8,12]. Therefore, the loss of oocyte BMP-6 and -
15 at ovulation undoubtedly plays an especially promi-
nent role in activating luteinization. Second, the fact that
CL BMP-2 expression is suppressed and activated during
luteinization and luteolysis, respectively, suggests that
BMP-2 might be a novel luteinization inhibitor. Further
work is necessary to investigate this possibility. Third, FS
is strongly expressed during luteinization, but is
undetectable at luteolysis. Thus, it is conceivable that the
cycle-specific expression of FS within the CL may control
the level of progesterone production through anti-BMP
mechanisms. And fourth, a role of BMPR-IB in luteogene-
sis was suggested by our finding that luteinization and
luteolysis, respectively are characterized by the absence
and presence of BMPR-IB expression in the CL. A func-
tional link between the expression of BMPR-IB and luteol-
ysis comes from loss-of-function studies showing that the
CL of the cycle continues to secrete progesterone in the ab-
sence of BMPR-IB [31]. This work, together with ourReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/9
Page 19 of 20
(page number not for citation purposes)
finding that BMPR-IB is selectively expressed in the TE of
the CL at luteolysis, supports the novel hypothesis that the
regulation of inducible and TE specific BMPR-IB gene ex-
pression may control luteolysis.
The observation that the ovarian sex cords (SC) express an
intrinsic BMP system replete with ligands (BMP-3b, -4, -7)
and receptors (BMPR-IA, -IB, -II) is novel. The SC are ves-
tiges of the cranial portion of the mesonephric tubules
and ducts, and in the adult ovary appear as a cluster of
blind tubules in the hilar region. Although little is known
about the physiology and biology of ovarian SC, they
have been linked to the genesis of ovary cancer through
distinct TGF-β signaling pathways [42,43]. Significantly,
the importance of FS in the genesis of this cancer has been
established [44]. Given the evidence that BMPs are potent
growth factors and that FS can modulate their bioactivity,
it will be interesting to investigate the possibility that this
intrinsic BMP system may be involved to pathogenesis of
SC tumors. Because SC were occasionally found juxta-
posed to developing follicles, blood vessels and secondary
interstitial cells, one cannot exclude the possibility that
the SC-derived BMPs may have paracrine functions.
A functional role for the BMPs in the ovary surface epithe-
lium (OSE) is suggested by the strong expression of BMP-
3b, -4, and -6. Based on our data, BMP-3b and -6 appear
to be constitutively expressed throughout the epithelium
over the cycle, a finding consistent with a maintenance-
type role for these OSE BMPs. An interesting finding is the
cell-specific induction of BMP-4 gene expression in a
subset of epithelial cells covering the ovulated follicle and
the newly formed CL-I. Although the function of this in-
ducible and cell-specific gene expression is unclear, it is
tightly correlated with the replenishment of the surface
epithelium that is exfoliated from the surface of ovulating
follicle. Thus, the importance of this highly specific ex-
pression of BMP-4 may relate to the regeneration of the
OSE during postovulatory repair. Although BMP-4 expres-
sion appears tightly regulated over the cycle, it remains to
be determined how the regulation is controlled. Because
the OSE does not appear to express BMP receptors, the
OSE-derived BMP-4 probably acts as a paracrine growth
factor in the underlying stroma. It is noteworthy that epi-
demiological studies have shown that the risk of epithelial
ovarian cancer is decreased by factors that suppress ovula-
tion, i.e., pregnancy, breast-feeding, and oral contracep-
tive pill. [45,46]. Given the relationship between LH-
dependent ovulation and the induction of BMP-4 expres-
sion, it will be important to explore a possible link be-
tween the risk of ovary cancer and the ovulation-inducible
and OSE cell-specific BMP-4 gene expression.
It is clear from this work that the regulation of inducible
and cell-specific expression of the BMP family is a general
property of the mammalian ovary. Consequently, the po-
tential for independent and coordinated contributions of
different BMPs to control growth, differentiation, and ap-
optosis is widely distributed throughout all the histologi-
cal units of the ovary. The current challenges are to
understand how specific hormone/growth factor interac-
tions regulate BMP expression in the fundamental ovary
cell types, and how these interactions are integrated into
the morphological and histological events that generate
the estrous cycle. The clinical relevance is emphasized by
our previous finding that the expression of GDF-9 is dys-
regulated in oocytes of women with Polycystic Ovary Syn-
drome [47].
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